Haematoporphyrin derivative (HpD) is the most widely used photosensitizer (PS) for photodynamic therapy (PDT) of cancer. In the present study it was found that L-buthionine-[S,R]sulfoximine (L-BSO), an inhibitor of glutathione (GSH) biosynthesis, added (jointly with HpD) to Ehrlich ascites carcinoma (EAC) cells for 5 min prior to photoirradiation (A, = 630 nm, the range 590-830 nm) enhanced synergistically the rate of HpD-sensitized photoinactivation of the cells. Thus, L-BSO, at a concentration of 2.5 mM caused (as measured by trypan blue test and MTT assay) a substantial (approximately 20%) increase in the HpD-induced photocytotoxicity. However, this effect of potentiation was not observed when chlorin-e4 trimethyl ester was used as a PS.Studies on the mechanism revealed that the potentiating action of L-BSO on HpD-PDT was not induced by lowering the reduced GSH (a natural antioxidant) content in EAC cells. At the same time, L-BSO was found to weakly but significantly augment the uptake of HpD by the cells at all concentrations used (from 0.5 up to 2.5 mM). This finding explains the potentiating effect of L-BSO on the HpD-induced photokilling of EAC cells.